| 1. |
|
|
| 2. |
|
|
| 3. |
- Semb, G, et al.
(author)
-
Erratum
- 2017
-
In: Journal of plastic surgery and hand surgery. - 2000-6764. ; 51:2, s. 158-158
-
Journal article (peer-reviewed)
|
|
| 4. |
- Mahdi, A., et al.
(author)
-
The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia
- 2023
-
In: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 293:2, s. 228-245
-
Journal article (peer-reviewed)abstract
- Background Patients with familial hypercholesterolemia (FH) display high levels of low-density lipoprotein cholesterol (LDL-c), endothelial dysfunction, and increased risk of premature atherosclerosis. We have previously shown that red blood cells (RBCs) from patients with type 2 diabetes induce endothelial dysfunction through increased arginase 1 and reactive oxygen species (ROS). Objective To test the hypothesis that RBCs from patients with FH (FH-RBCs) and elevated LDL-c induce endothelial dysfunction. Methods and results FH-RBCs and LDL-c >5.0 mM induced endothelial dysfunction following 18-h incubation with isolated aortic rings from healthy rats compared to FH-RBCs and LDL-c <2.5 mM or RBCs from healthy subjects (H-RBCs). Inhibition of vascular but not RBC arginase attenuated the degree of endothelial dysfunction induced by FH-RBCs and LDL-c >5.0 mM. Furthermore, arginase 1 but not arginase 2 was elevated in the vasculature of aortic segments after incubation with FH-RBCs and LDL-c >5.0 mM. A superoxide scavenger, present throughout the 18-h incubation, attenuated the degree of endothelial dysfunction induced by FH-RBCs and LDL-c >5.0 mM. ROS production was elevated in these RBCs in comparison with H-RBCs. Scavenging of vascular ROS through various antioxidants also attenuated the degree of endothelial dysfunction induced by FH-RBCs and LDL-c >5.0 mM. This was corroborated by an increase in the lipid peroxidation product 4-hydroxynonenal. Lipidomic analysis of RBC lysates did not reveal any significant changes across the groups. Conclusion FH-RBCs induce endothelial dysfunction dependent on LDL-c levels via arginase 1 and ROS-dependent mechanisms.
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Brinck, J., et al.
(author)
-
Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
- 2022
-
In: Diabetes care. - : American Diabetes Association. - 0149-5992 .- 1935-5548. ; 45:12, s. 3040-3049
-
Journal article (peer-reviewed)abstract
- OBJECTIVE Patients with diabetes or familial hypercholesterolemia (FH) have an increased incidence of cardiovascular diseases compared with the population, but whether this risk is exacerbated in patients with combined traits is unknown. RESEARCH DESIGN AND METHODS In this Swedish nationwide, register-based cohort study, patients with diabetes were included between 2002 and 2020. Adjusted Cox proportional hazards models were used to assess the risk of cardiovascular events in patients with or without phenotypic FH (‡6 points for phenotypic FH according to Dutch Lipid Clinic Network criteria) compared with general population control subjects without diabetes as reference. RESULTS A total of 45,585 patients with type 1 diabetes (227,923 control subjects) and 655,250 patients with type 2 diabetes (655,250 control subjects) were followed for a median of 14.1 and 7.9 years, respectively. Of those, 153 and 7,197, respectively, had phenotypic FH. Compared with control subjects, patients with diabetes and phenotypic FH had higher risk of cardiovascular mortality (type 1: Hazard ratio 21.3 [95% CI 14.6-31.0]; type 2: 2.40 [2.19-2.63]) and of a cardiovascular event (type 1: 15.1 [11.1-20.5]; type 2: 2.73 [2.58-2.89]). Further, patients with diabetes and phenotypic FH had higher LDL-cholesterol levels during observation (P < 0.05) and increased risk of all major cardiovascular outcomes (P < 0.0001) than patients with diabetes but without FH. The proportion receiving lipid-lowering treatment was higher in patients with phenotypic FH (P < 0.0001). CONCLUSIONS Patients with both diabetes and phenotypic FH are more at risk for adverse cardiovascular outcomes and have higher LDL-cholesterol levels despite receiving intensified lipid-lowering therapy.
|
|
| 9. |
- Brinck, J, et al.
(author)
-
Influence of pH on the adsorptive fouling of ultrafiltration membranes by fatty acid
- 2000
-
In: Journal of Membrane Science. - 0376-7388 .- 1873-3123. ; 164:1-2, s. 187-194
-
Journal article (peer-reviewed)abstract
- Fatty acids are found in many solutions treated in ultrafiltration plants, for example, in dairy products, fermentation broth, oily waste water and bleach plant effluents from pulp mills. The influence of fatty acids on the fouling of membranes is often ignored because their concentration is rather low. However, during recent years the significant influence of fatty acids on the flux reduction of ultrafiltration membranes has attracted much attention. The pore radius of the membrane, the concentration of fatty acids and the pH of the solution all have a profound influence on the flux reduction when treating solutions containing fatty acids. In the work presented in this paper, the influence of pH on the flux reduction of an ultrafiltration membrane made of polyethersulphone was studied. It was found that there was no flux reduction under alkaline conditions, whereas the flux reduction under acidic conditions was severe. In order to elucidate the adsorption process, the adsorption of octanoic acid on a planar, hydrophobized silica surface was studied by means of in situ null ellipsometry. In the ellipsometry study a sharp increase in the amount adsorbed was observed when the concentration of undissociated acid approached the saturation concentration as the pH was decreased. This explains the observed flux reduction under acidic conditions. (C) 2000 Elsevier Science B.V. All rights reserved.
|
|
| 10. |
|
|
